Patrick F Smith sold $243k of CERT
PRESIDENT, DRUG DEV SOLUTIONS at Certara, Inc.. 14,427 shares at an average of $16.85, traded Apr 2, 2024, filed Apr 4, 2024.
Score components
- +20RolePresident
- +13Trade size$243k at market
- +5Share of holdings soldSold 22% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.8%, 3m -22.0%, 6m -38.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-010291, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 2, 2024 | SOpen-market sale Common Stock10b5-1 | -5,264 | $16.76 | $88k | 59,254 | Apr 4, 2024 |
| Apr 2, 2024 | SOpen-market sale Common Stock10b5-1 | -649 | $17.72 | $12k | 58,605 | Apr 4, 2024 |
| Apr 2, 2024 | SOpen-market sale Common Stock10b5-1 | -3,024 | $16.75 | $51k | 55,581 | Apr 4, 2024 |
| Apr 2, 2024 | SOpen-market sale Common Stock10b5-1 | -328 | $17.67 | $5,796 | 55,253 | Apr 4, 2024 |
| Apr 2, 2024 | SOpen-market sale Common Stock10b5-1 | -4,740 | $16.77 | $79k | 50,513 | Apr 4, 2024 |
| Apr 2, 2024 | SOpen-market sale Common Stock10b5-1 | -422 | $17.77 | $7,499 | 50,091 | Apr 4, 2024 |
Related signals
Other insiders at Certara, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | CERTbuy Certara, Inc. | William F Feehery CHIEF EXECUTIVE OFFICER | $200k 24,096 shares | +1% | |
| 29Weak | Certara, Inc. | Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF | $559k 51,224 shares | -41% | |
| 7Weak | Certara, Inc. | Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS | $60k 5,409 shares | -10% | |
| 29Weak | Certara, Inc. | Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF | $578k 51,224 shares | -34% | |
| 0Weak | Certara, Inc. | Richard M. Traynor SVP AND GENERAL COUNSEL | $54k 3,000 shares | -2% | |
| 10Weak | Certara, Inc. | Richard M. Traynor SVP AND GENERAL COUNSEL | $55k 3,000 shares | -2% | |
| 17Weak | Certara, Inc. | Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS | $90k 5,000 shares | -8% | |
| 13Weak | Certara, Inc. | Richard M. Traynor SVP AND GENERAL COUNSEL | $108k 6,000 shares | -4% | |
| 5Weak | Certara, Inc. | Richard M. Traynor SVP AND GENERAL COUNSEL | $108k 6,000 shares | -3% | |
| 57Moderate | CERTsell Certara, Inc. | EQT Avatar Parent L.P. owner | $449M 29,954,521 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.